Found 13 matching trials
A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) PHASE3 This is a prospective open-label, uncontrolled, single-blind, pilot clinica...
Show More Location
University of Alberta
Learn More & Join Trial
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis PHASE2 The purpose of this study is to determine whether Hizentra is a safe and ef...
Show More Location
Phoenix Neurological Associates
Learn More & Join Trial
Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) PHASE4 This multicenter, open-label, parallel-arm, non-randomized study is designe...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS PHASE3 This is a prospective, phase 3, multicenter, double-blind, randomized place...
Show More Location
University of Alabama Hospital at Birmingham
Learn More & Join Trial
Hizentra® in Inflammatory Neuropathies - pHeNIx Study N/A The pHeNIx study, a national multicentre prospective non-interventional stu...
Show More Location
CHU Amiens Picardie 1
Learn More & Join Trial
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma PHASE3 The main goal of this study is to show that people with certain immune prob...
Show More Learn More & Join Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) PHASE3 This is a phase 3, multicenter, randomized, placebo-controlled, double-blin...
Show More Location
8401117 - Arizona Arthritis & Rheumatology Research
Learn More & Join Trial
Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency PHASE4 The purpose of this open-label study is to evaluate the pharmacokinetics, s...
Show More Location
Childrens Hospital Los Angeles
Learn More & Join Trial
Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules PHASE4 The purpose of the study is to assess the impact of immunoglobulin treatmen...
Show More Location
Centre Hospitalier de l'université de Montréal
Learn More & Join Trial
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia PHASE1 The Children Liver Disease Research and Education Network (ChiLDREN) is con...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial